Verition Fund Management LLC Aldeyra Therapeutics, Inc. Transaction History

Verition Fund Management LLC

$17.4 Billion
Q3 2024

A detailed history of Verition Fund Management LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 33,530 shares of ALDX stock, worth $160,608. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,530

Previous 219,827 84.75%

Holding current value

$160,608

Previous $727,000 75.24%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.19 - $6.32 $594,287 - $1.18 Million	-186,297 Reduced 84.75%	33,530 $180,000
Q2 2024 Aug 14, 2024	SELL	$3.25 - $4.72 $2.34 Million - $3.4 Million	-720,571 Reduced 76.62%	219,827 $727,000
Q1 2024 May 14, 2024	SELL	$2.77 - $4.22 $1.06 Million - $1.62 Million	-384,436 Reduced 29.02%	940,398 $3.08 Million
Q4 2023 Feb 14, 2024	BUY	$1.47 - $6.06 $572,654 - $2.36 Million	389,561 Added 41.65%	1,324,834 $4.65 Million
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $31,765 - $42,423	5,199 Added 0.56%	935,273 $6.25 Million
Q2 2023 Aug 14, 2023	SELL	$7.11 - $11.89 $4.51 Million - $7.55 Million	-634,954 Reduced 40.57%	930,074 $7.8 Million
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $38,693 - $66,590	6,706 Added 0.43%	1,565,028 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$5.08 - $7.09 $4.29 Million - $5.98 Million	-843,917 Reduced 35.13%	1,558,322 $10.8 Million
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $1.9 Million - $3.88 Million	501,048 Added 26.35%	2,402,239 $12.8 Million
Q2 2022 Aug 15, 2022	SELL	$2.43 - $4.85 $497,459 - $992,872	-204,716 Reduced 9.72%	1,901,191 $7.59 Million
Q1 2022 May 13, 2022	BUY	$3.25 - $5.17 $2.4 Million - $3.82 Million	739,206 Added 54.09%	2,105,907 $9.36 Million
Q4 2021 Feb 14, 2022	BUY	$3.5 - $9.63 $2.51 Million - $6.92 Million	718,494 Added 110.84%	1,366,701 $5.47 Million
Q3 2021 Nov 15, 2021	BUY	$7.94 - $11.31 $955,785 - $1.36 Million	120,376 Added 22.81%	648,207 $5.69 Million
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $1.16 Million - $1.65 Million	111,114 Added 26.66%	527,831 $5.98 Million
Q1 2021 May 18, 2021	BUY	$6.53 - $14.42 $1.44 Million - $3.17 Million	219,963 Added 111.8%	416,717 $4.95 Million
Q4 2020 Feb 16, 2021	SELL	$6.31 - $8.13 $627,378 - $808,333	-99,426 Reduced 33.57%	196,754 $1.35 Million
Q3 2020 Nov 16, 2020	BUY	$4.0 - $7.53 $1.1 Million - $2.06 Million	274,180 Added 1246.27%	296,180 $2.2 Million
Q2 2020 Aug 14, 2020	BUY	$1.97 - $5.05 $43,340 - $111,100	22,000 New	22,000 $92,000
Q2 2019 Aug 14, 2019	SELL	$6.0 - $9.0 $1.65 Million - $2.48 Million	-275,205 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $888,216 - $1.23 Million	124,400 Added 82.49%	275,205 $2.49 Million
Q4 2018 Feb 14, 2019	BUY	$7.26 - $13.29 $1.09 Million - $2 Million	150,805 New	150,805 $1.25 Million

Others Institutions Holding ALDX

# of Institutions

117

Shares Held

36.4M

Call Options Held

196K

Put Options Held

142K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $279M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Account

Verition Fund Management LLC Aldeyra Therapeutics, Inc. Transaction History